Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline
San Mateo, Calif, Nov 14, 2018 – Attenua, Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines to treat […]
Attenua